Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11786553 Chimeric cytokine receptors bearing a PD-1 ectodomain

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
February 28, 2020
Date of Patent
October 17, 2023
Patent Applicant
Allogene Therapeutics
Allogene Therapeutics
Patent Application Number
16804545
Patent Citations
‌
US Patent 10287354 Regulatable chimeric antigen receptor
‌
US Patent 10294304 Chimeric antigen receptors targeting B-cell maturation antigen
‌
US Patent 10548921 Reversing the effects of the tumor microenvironment using chimeric cytokine receptors
‌
US Patent 10336810 Chimeric antigen receptors, encoding nucleic acids and methods of use thereof
‌
US Patent 8389282 Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
‌
US Patent 9434935 Modified caspase polypeptides and uses thereof
‌
US Patent 9913882 Methods for inducing partial apoptosis using caspase polypeptides
‌
US Patent 9944690 Methods for controlling T cell proliferation
Patent Inventor Names
Siler Panowski
Regina Junhui Lin
Barbra Johnson Sasu
Thomas John Van Blarcom
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11786553
Patent Primary Examiner
‌
Hong Sang
CPC Code
‌
C07K 14/715
‌
C07K 2319/33
‌
C07K 2319/74
‌
C12N 5/0636
‌
A61K 35/17
‌
C07K 2319/03
‌
C07K 14/7155

Find more entities like US Patent 11786553 Chimeric cytokine receptors bearing a PD-1 ectodomain

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.